Targanox Overview
- Year Founded
-
2008
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Targanox General Information
Description
Developer of therapeutic drugs designed to prevent stress induced diseases. The company's drugs curb a disease-related biochemical condition called oxidative stress and specifically targets oxidized cystine residues of key proteins involved in human diseases, enabling patients to get advanced medicines for their diseases that help them to recover faster.
Contact Information
Website
www.targanox.comCorporate Office
- 37 Spinelli Place
- Cambridge, MA 02138
- United States
Corporate Office
- 37 Spinelli Place
- Cambridge, MA 02138
- United States
Targanox Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Nov-2016 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 30-Mar-2009 | Completed | Startup |
Targanox Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Targanox FAQs
-
When was Targanox founded?
Targanox was founded in 2008.
-
Where is Targanox headquartered?
Targanox is headquartered in Cambridge, MA.
-
What industry is Targanox in?
Targanox’s primary industry is Drug Discovery.
-
Is Targanox a private or public company?
Targanox is a Private company.
-
What is Targanox’s current revenue?
The current revenue for Targanox is .
-
How much funding has Targanox raised over time?
Targanox has raised $5.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process